APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 170 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $15,805,395 | +40.0% | 173,495 | +1.4% | 0.05% | +35.9% |
| Q1 2023 | $11,286,350 | +49.8% | 171,109 | +17.4% | 0.04% | +44.4% |
| Q4 2022 | $7,534,354 | -62.3% | 145,704 | -50.3% | 0.03% | -30.8% |
| Q3 2022 | $20,010,130 | +182.6% | 292,976 | +87.1% | 0.04% | +200.0% |
| Q2 2022 | $7,081,952 | +35.6% | 156,610 | +89.5% | 0.01% | +62.5% |
| Q2 2021 | $5,222,000 | +173.7% | 82,642 | +85.9% | 0.01% | +33.3% |
| Q1 2021 | $1,908,000 | -84.2% | 44,461 | -78.9% | 0.01% | -84.2% |
| Q4 2020 | $12,075,000 | +111.3% | 211,108 | +11.4% | 0.04% | +81.0% |
| Q3 2020 | $5,715,000 | -48.7% | 189,427 | -44.5% | 0.02% | -4.5% |
| Q2 2020 | $11,146,000 | +29.6% | 341,268 | +6.3% | 0.02% | +4.8% |
| Q1 2020 | $8,600,000 | +48.9% | 320,982 | +70.2% | 0.02% | +75.0% |
| Q4 2019 | $5,774,000 | – | 188,582 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |